The SELECT trial (Lincoff et al., NEJM 2023, NCT03574597) extended Semaglutide research to cardiovascular outcomes in 17,604 adults with obesity and prior cardiovascular disease (no T2D) over a mean ~34-month follow-up
Can you take Ozempic if you are pregnant
doi: 10.3390/molecules24162930 113 HassaninasabAHashimotoYTomita-YokotaniKKobayashiM
Biol Res 2:7982 Bradamante S, Barenghi L, Piccinini F, Bertelli AA, De Jonge R, Beemster P, De Jong JW (2003) Resveratrol provides late-phase cardioprotection by means of a nitric oxide-and adenosine-mediated mechanism
Those figures explain why GLP-1 receptor agonist medications have moved from endocrinology clinics to dinner-table conversation in only a few years
Adelhorst K, Hedegaard BB, Knudsen LB, Kirk O